These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 33577785)

  • 1. Proteogenomic and metabolomic characterization of human glioblastoma.
    Wang LB; Karpova A; Gritsenko MA; Kyle JE; Cao S; Li Y; Rykunov D; Colaprico A; Rothstein JH; Hong R; Stathias V; Cornwell M; Petralia F; Wu Y; Reva B; Krug K; Pugliese P; Kawaler E; Olsen LK; Liang WW; Song X; Dou Y; Wendl MC; Caravan W; Liu W; Cui Zhou D; Ji J; Tsai CF; Petyuk VA; Moon J; Ma W; Chu RK; Weitz KK; Moore RJ; Monroe ME; Zhao R; Yang X; Yoo S; Krek A; Demopoulos A; Zhu H; Wyczalkowski MA; McMichael JF; Henderson BL; Lindgren CM; Boekweg H; Lu S; Baral J; Yao L; Stratton KG; Bramer LM; Zink E; Couvillion SP; Bloodsworth KJ; Satpathy S; Sieh W; Boca SM; Schürer S; Chen F; Wiznerowicz M; Ketchum KA; Boja ES; Kinsinger CR; Robles AI; Hiltke T; Thiagarajan M; Nesvizhskii AI; Zhang B; Mani DR; Ceccarelli M; Chen XS; Cottingham SL; Li QK; Kim AH; Fenyö D; Ruggles KV; Rodriguez H; Mesri M; Payne SH; Resnick AC; Wang P; Smith RD; Iavarone A; Chheda MG; Barnholtz-Sloan JS; Rodland KD; Liu T; Ding L;
    Cancer Cell; 2021 Apr; 39(4):509-528.e20. PubMed ID: 33577785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-scale signaling and tumor evolution in high-grade gliomas.
    Liu J; Cao S; Imbach KJ; Gritsenko MA; Lih TM; Kyle JE; Yaron-Barir TM; Binder ZA; Li Y; Strunilin I; Wang YT; Tsai CF; Ma W; Chen L; Clark NM; Shinkle A; Naser Al Deen N; Caravan W; Houston A; Simin FA; Wyczalkowski MA; Wang LB; Storrs E; Chen S; Illindala R; Li YD; Jayasinghe RG; Rykunov D; Cottingham SL; Chu RK; Weitz KK; Moore RJ; Sagendorf T; Petyuk VA; Nestor M; Bramer LM; Stratton KG; Schepmoes AA; Couvillion SP; Eder J; Kim YM; Gao Y; Fillmore TL; Zhao R; Monroe ME; Southard-Smith AN; Li YE; Jui-Hsien Lu R; Johnson JL; Wiznerowicz M; Hostetter G; Newton CJ; Ketchum KA; Thangudu RR; Barnholtz-Sloan JS; Wang P; Fenyö D; An E; Thiagarajan M; Robles AI; Mani DR; Smith RD; Porta-Pardo E; Cantley LC; Iavarone A; Chen F; Mesri M; Nasrallah MP; Zhang H; Resnick AC; Chheda MG; Rodland KD; Liu T; Ding L; ;
    Cancer Cell; 2024 Jul; 42(7):1217-1238.e19. PubMed ID: 38981438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative multi-omics characterization reveals sex differences in glioblastoma.
    Jang B; Yoon D; Lee JY; Kim J; Hong J; Koo H; Sa JK
    Biol Sex Differ; 2024 Mar; 15(1):23. PubMed ID: 38491408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
    Patil V; Mahalingam K
    Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.
    Oh S; Yeom J; Cho HJ; Kim JH; Yoon SJ; Kim H; Sa JK; Ju S; Lee H; Oh MJ; Lee W; Kwon Y; Li H; Choi S; Han JH; Chang JH; Choi E; Kim J; Her NG; Kim SH; Kang SG; Paek E; Nam DH; Lee C; Kim HS
    Nat Commun; 2020 Jul; 11(1):3288. PubMed ID: 32620753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of RNA-Seq and proteomics data identifies glioblastoma multiforme surfaceome signature.
    Syafruddin SE; Nazarie WFWM; Moidu NA; Soon BH; Mohtar MA
    BMC Cancer; 2021 Jul; 21(1):850. PubMed ID: 34301218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteogenomics of glioblastoma associates molecular patterns with survival.
    Yanovich-Arad G; Ofek P; Yeini E; Mardamshina M; Danilevsky A; Shomron N; Grossman R; Satchi-Fainaro R; Geiger T
    Cell Rep; 2021 Mar; 34(9):108787. PubMed ID: 33657365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.
    Doll S; Urisman A; Oses-Prieto JA; Arnott D; Burlingame AL
    Mol Cell Proteomics; 2017 Jan; 16(1):39-56. PubMed ID: 27834733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteogenomic characterization of glioblastoma.
    Asif S; Fatima R; Krc R; Bennett J; Raza S
    CNS Oncol; 2019 Jun; 8(2):CNS37. PubMed ID: 31290679
    [No Abstract]   [Full Text] [Related]  

  • 10. Multi-Omics Data Integration and Mapping of Altered Kinases to Pathways Reveal Gonadotropin Hormone Signaling in Glioblastoma.
    Jayaram S; Gupta MK; Raju R; Gautam P; Sirdeshmukh R
    OMICS; 2016 Dec; 20(12):736-746. PubMed ID: 27930095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Proteogenomics Uncover Mechanisms of Glioblastoma Evolution, Pointing to Novel Therapeutic Targets.
    Li J; Shih LK; Brat DJ
    Cancer Res; 2024 May; 84(9):1379-1381. PubMed ID: 38330148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation.
    Tripathi PH; Akhtar J; Arora J; Saran RK; Mishra N; Polisetty RV; Sirdeshmukh R; Gautam P
    BMC Cancer; 2022 Feb; 22(1):133. PubMed ID: 35109816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
    Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
    J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
    Brown KE; Chagoya G; Kwatra SG; Yen T; Keir ST; Cooter M; Hoadley KA; Rasheed A; Lipp ES; Mclendon R; Ali-Osman F; Bigner DD; Sampson JH; Kwatra MM
    J Neurochem; 2015 Jun; 133(5):730-8. PubMed ID: 25598002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
    Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S
    Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.
    Conroy S; Wagemakers M; Walenkamp AM; Kruyt FA; den Dunnen WF
    J Neurooncol; 2017 Jan; 131(1):11-20. PubMed ID: 27633774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.
    Babačić H; Galardi S; Umer HM; Hellström M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
    Mol Oncol; 2023 Feb; 17(2):238-260. PubMed ID: 36495079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma.
    Luo D; Luo A; Hu S; Ye G; Li D; Zhao H; Peng B
    Sci Rep; 2024 Jul; 14(1):17630. PubMed ID: 39085480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
    Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
    Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.